September 9: From Niche to Necessary: Genetic Counselor-Led Pharmacogenomics Across the Care Continuum

Hannah Llorin, MS, CGC, is a certified genetic counselor and Director of Genetic Counseling at Atria Health and Research Institute in New York, NY. Her work integrates genomic medicine into primary care through clinical and technical strategies that enable genetics to inform routine healthcare decisions. As a GC-FIRST Research Fellow at University of Minnesota, she studies pharmacogenomics implementation and clinical outcomes. Ms. Llorin previously practiced clinically at Brigham and Women's Hospital Center for Fetal Medicine and worked in genetics education at 23andme. She serves on the advisory board for Stanford University's MS Program in Human Genetics and Genetic Counseling, where she is an alumna. She formerly served as executive editor for the National Society of Genetic Counselors' Perspectives in Genetic Counseling, and contributes to national initiatives on inclusive genetic counseling practices.

Elizabeth Fieg is a genetic counselor with experience working in adult medical genetics, endocrine genetics, rare disease research, and pharmacogenomics. Elizabeth is a member of CPIC and previously served in the ClinGen Pharmacogenomics Working Group. She is a clinical science liaison on the medical affairs team at Baylor Genetics and is involved in the Undiagnosed Disease Network (UDN). Elizabeth is an Adjunct Assistant Professor in the Genetic Counseling program at the MGH Institute of Health Professions.

Hetanshi Naik is an Associate Professor in the Department of Genetics and the Research Director of the MS Program in Human Genetics and Genetic Counseling. She is a clinical researcher with expertise in the Porphyrias, lysosomal storage disorders (LSDs), and pharmacogenomics. Her research focuses on developing and evaluating patient reported outcomes (PROs) for genetic disorders and genomic medicine implementation, in particular assessing PROs as outcomes for rare disease trials, pharmacogenomics implementation, and genetic counseling education and processes.

Jen Eichmeyer received her Master's in Genetic Counseling at the University of Texas at Houston in 2002. Jennifer has expertise in creating and developing new clinical genetic services including cancer genetics, telehealth genetic counseling services, and pharmacogenetics. She lectures to multiple genetic counseling training programs on PGx and has been a leader in PGx in the National Society of Genetic Counselors. She established a private practice that served PGx indications and continues to be part of PGx professional organizations such as CPIC and STRIPE.

Jeri spent 12 years as a genetic counselor focused on prenatal genetics before returning to school to earn her Doctor of Pharmacy degree. Driven by a desire to blend her passion for genetics with her pharmacy training, she launched GenePharmer, LLC. Through this work, Jeri partners with patients and providers to deliver personalized pharmacogenomic guidance.

Carla McGruder, MS, CGC, is a Senior Clinical Genetic Counselor at Color Health, where she leads innovative work in virtual cancer care and risk assessment. Her expertise spans cancer genetics, pharmacogenomics, cardiology, and the integration of clinical care with digital health solutions. She is passionate about expanding access to genetic services and advancing equity in healthcare. In addition to her clinical work, Carla provides educational genetic counseling services through Good Genes Genetic Counseling Services, LLC. She earned her Master of Science in Genetic Counseling from the University of Texas Health Science Center at Houston.